These results suggest that AMPKα1 plays a critical role in protecting breast cancer cells against doxorubicin-induced cytotoxicity, further indicating that AMPKα1 is a cellular factor that contributes to determining cellular susceptibility to doxorubicin. This evidence concerns the gene PRKAA1 and breast carcinoma.